Renosen Pharmaceuticals Private Ltd's Insider Trades & SAST Disclosures
No reported Insider Trades available for Renosen Pharmaceuticals Private Ltd in the Trendlyne database.
Renosen Pharmaceuticals Private Ltd's has made SAST transactions in Remus Pharmaceuticals Ltd. recently where a Acquisition of 600 Equity shares done . Disclosure was reported to the exchange on Feb. 4, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharma | Renosen Pharmaceuticals Private Ltd | Promoter | Acquisition | 05 Feb 2025 | 600 | 53,900 | - | - | 03 Feb 2025 03 Feb 2025 |
SAST (Reg29(2)) | Equity shares | Open Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.